trem2 apc (R&D Systems)
Structured Review

Trem2 Apc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 46 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/trem2 apc/product/R&D Systems
Average 95 stars, based on 46 article reviews
Images
1) Product Images from "YAP/TEAD drives treatment-induced adaptive immunosuppression in EGFR-mutant lung cancer"
Article Title: YAP/TEAD drives treatment-induced adaptive immunosuppression in EGFR-mutant lung cancer
Journal: bioRxiv
doi: 10.64898/2026.01.22.701073
Figure Legend Snippet: A) GSEA analysis of MoMacVERSE monocyte/macrophage signatures using RNA-sequencing data from . B) GSEA enrichment plots of two independent TREM2 + macrophage signatures , . C) GSEA of Hallmark genes. D) Flow cytometry analysis of TREM2 surface expression in monocyte-derived macrophages exposed to HCC827 CM. E) Immunohistochemical staining of TREM2 from syngeneic Del19.2 model in vivo experiment depicted in . F) Quantification of TREM2 + area from samples in (E) using QuPath. G) TREM2 gene expression in EGFR TKI-treated patients. RNA-sequencing data from Gurule et al. . H) Correlation of macrophage and T cell abundance from CIBERSORTx analysis of RNA sequencing data in (G). CM = conditioned medium. Paired (D) or unpaired (F) t-tests were used to assess statistical significance. **, P-value <0.01; *, P-value < 0.05.
Techniques Used: RNA Sequencing, Flow Cytometry, Expressing, Derivative Assay, Immunohistochemical staining, Staining, In Vivo, Gene Expression
Figure Legend Snippet: A) Experimental set-up for conditioned media collection and YAP/TEAD inhibition in DTP cells. B) RNA-sequencing analysis of the expression of genes encoding for secreted proteins in HCC827 and HCC4006 cell lines treated as in (A). C) YAP-driven secretome in HCC827 and HCC4006 cells, determined by genes upregulated in DTPs, and downregulated upon TEAD inhibition. D) Shared YAP-driven secretome in HCC827 and HCC4006. E) ChIP-seq analysis of YAP binding of shared secretome genes. F) List of shared YAP-driven secretome from (D), with genes previously associated with macrophage activation, migration, or polarization highlighted in bold. G) CD163 expression of THP-1 cells treated with HCC827 conditioned media collected as in (A) using 500 nM ORM-47286 or 10 mM MYF-01-37 for TEAD inhibition. H) Flow cytometry analysis of CD163 and TREM2 cell surface expression in human peripheral blood monocytes exposed to HCC827 conditioned media. Data in (G) presented as mean ± SD. Unpaired (G) and paired (H) one-way ANOVA was used to assess statistical significance. **, P-value <0.01; *, P-value < 0.05.
Techniques Used: Inhibition, RNA Sequencing, Expressing, ChIP-sequencing, Binding Assay, Activation Assay, Migration, Flow Cytometry

![Representative plots illustrate the sequential gating of SVF cells, including singlet and CD45 populations, macrophages (CD11bF4/80), and downstream subsets (CD11c, CD206, CD9, <t>TREM2).</t> Gates are indicated to show the strategy used for analysis and sorting. This figure is intended as a schematic overview of the gating hierarchy; detailed quantitative data and subset percentages are reported in Wu et al. [16].](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_0519/pmc12550519/pmc12550519__BioProtoc-15-20-5479-g004.jpg)